Literature DB >> 5768127

The cardio-toxicity of isoprenaline during hypoxia.

J M Collins, D G McDevitt, R G Shanks, J G Swanton.   

Abstract

1. The effects of the intravenous injection of isoprenaline on heart rate and arterial pressure has been studied in dogs artificially respired with room air or with 12% oxygen-88% nitrogen.2. In dogs breathing room air, isoprenaline in doses from 0.02 to 500 mug/kg increased heart rate and reduced arterial pressure. Ventricular fibrillation was produced in one out of three dogs given 250 mug/kg. This was the only dog breathing room air which was killed by isoprenaline.3. In dogs breathing room air the repeated intravenous injection at 5-min intervals of 2.5 mug/kg increased heart rate and reduced arterial pressure. No ill effects were produced by six doses.4. In dogs respired with 12% oxygen-88% nitrogen the PaO(2) was reduced from 84 to 38 mm Hg with no changes in PaCO(2). In these dogs death was produced by doses of isoprenaline which in dogs breathing room air produced normal responses.5. The fatal dose of isoprenaline (10-50 mug/kg) reduced heart rate and arterial and pulse pressures; sinus rhythm persisted until arterial pressure was less than 50 mm Hg. Ventricular fibrillation did not occur; death occurred from cardiac asystole.6. Death was produced in a similar way in dogs with hypoxaemia by giving four or five doses of isoprenaline (2.5 mug/kg) at 5-min intervals or by two doses of 25 mug/kg.7. The final reduction in arterial pressure during a fatal response resulted from a reduction in cardiac contractility.8. These lethal effects of isoprenaline could be prevented by pretreatment with propranolol.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5768127      PMCID: PMC1703542          DOI: 10.1111/j.1476-5381.1969.tb08301.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Blood-gas tensions in bronchial asthma.

Authors:  E Tai; J Read
Journal:  Lancet       Date:  1967-03-25       Impact factor: 79.321

2.  Spirometry and blood-gas tensions in bronchial asthma and chronic bronchitis.

Authors:  K N Palmer; M L Diament
Journal:  Lancet       Date:  1967-08-19       Impact factor: 79.321

3.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

4.  Observations on recent increase in mortality from asthma.

Authors:  F E Speizer; R Doll; P Heaf
Journal:  Br Med J       Date:  1968-02-10

5.  The reported increase in mortality from asthma: a clinico-functional analysis.

Authors:  J Read
Journal:  Med J Aust       Date:  1968-05-25       Impact factor: 7.738

6.  Gas exchange in the acute and asymptomatic phases of asthma breathing air and oxygen.

Authors:  P Valabhji
Journal:  Clin Sci       Date:  1968-06       Impact factor: 6.124

7.  The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog.

Authors:  R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1966-02

8.  Blood pressure and flow in the ascending aorta of conscious dogs.

Authors:  M I Noble; I T Gabe; D Trenchard; A Guz
Journal:  Cardiovasc Res       Date:  1967-01       Impact factor: 10.787

9.  Effect of beta adrenergic blockade on the hemodynamic responses to epinephrine in man.

Authors:  W S Harris; C D Schoenfeld; R H Brooks; A M Weissler
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

10.  Investigation into use of drugs preceding death from asthma.

Authors:  F E Speizer; R Doll; P Heaf; L B Strang
Journal:  Br Med J       Date:  1968-02-10
View more
  26 in total

1.  Intravenous treatment with rimiterol and salbutamol in asthma.

Authors:  G E Marlin; P Turner
Journal:  Br Med J       Date:  1975-06-28

2.  Concerns regarding the current use of beta-agonists in the therapy of asthma.

Authors:  G Aberg; J Costello
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

3.  Prevalence of asthma among schoolchildren in Patras, Greece: three surveys over 20 years.

Authors:  M Anthracopoulos; A Karatza; E Liolios; M Triga; K Triantou; K Priftis
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

4.  Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.

Authors:  J Burggraaf; R G Westendorp; J C in't Veen; R C Schoemaker; P J Sterk; A F Cohen; G J Blauw
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

5.  Metabolic effects of salbutamol: comparison of aerosol and intravenous administration.

Authors:  A Neville; J B Palmer; J Gaddie; C S May; K N Palmer; L E Murchison
Journal:  Br Med J       Date:  1977-02-12

6.  Resistance to beta-adrenoceptor stimulants.

Authors: 
Journal:  Br Med J       Date:  1972-01-15

7.  Death from asthma.

Authors:  C Collins-Williams; C Zalesky; K Battu; M T Chambers
Journal:  Can Med Assoc J       Date:  1981-08-15       Impact factor: 8.262

8.  Comparison of the effects of isoprenaline, orciprenaline, salbutamol and isoetharine on the cardiovascular system of anaesthetized dogs.

Authors:  J M Ekue; R G Shanks; S A Zaidi
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

9.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

Authors:  N Pearce; J Grainger; M Atkinson; J Crane; C Burgess; C Culling; H Windom; R Beasley
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

10.  Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).

Authors:  M E Conolly; D S Davies; C T Dollery; C F George
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.